BDBM237545 2-[(3aR,5R,6aS)-5- hydroxy-5-{[4- (trifluoromethyl)phenyl] methyl}- octahydrocyclopenta[c] pyrrol-2-yl]-1-(5- hydroxypyridin-2- yl)ethan-1-one::US10052306, 216::US10052306, 217

SMILES Oc1ccc(nc1)C(=O)CN1C[C@H]2C[C@](O)(Cc3ccc(cc3)C(F)(F)F)C[C@H]2C1

InChI Key InChIKey=BMMLNZKVNBGERU-VPTLXERWSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 237545   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM237545(2-[(3aR,5R,6aS)-5- hydroxy-5-{[4- (trifluoromethyl...)
Affinity DataIC50:  36nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM237545(2-[(3aR,5R,6aS)-5- hydroxy-5-{[4- (trifluoromethyl...)
Affinity DataIC50:  803nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent